セッション詳細
[BIO]International Session(Platform Presentation)優秀演題賞セッション
2025年6月5日(木) 13:35 〜 14:35
第8会場
Chair:Naoko Ishihara (Department of Pediatrics, Fujita Health University School of Medicine, Aichi, Japan),Tohru Okanishi(Division of Child Neurology, Institute of Neurological Sciences, Faculty of Medicine, Tottori University, Tottori, Japan)
[BIO-01]Prenatal Psychological Distress on the Development of Epilepsy in Offspring:The Japan Environment and Children’s Study
○Yuto Arai1, Tohru Okanishi1, Toshio Masumoto2, Hisashi Noma3, Yoshihiro Maegaki1 (1.Division of Child Neurology, Department of Brain and Neurosciences, Faculty of Medicine, Tottori University, Tottori, Japan, 2.Division of Health Administration and Promotion, Department of Social Medicine, Faculty of Medicine, Tottori University, Tottori, Japan, 3.Department of Data Science, The Institute of Statistical Mathematics, Tokyo, Japan)
[BIO-02]Evidence of thalamocortical network activation during epileptic spasms: a thalamic stereotactic EEG study
○Atsuro Daida1,2, Saarang Panchavati2, Shingo Oana1, Sotaro Kanai1, Yipeng Zhang3, Yuanyi Ding3, Rajaraman R Rajsekar1, Noriko Salamon4, Raman Sankar1, Aria Fallah5, Shaun A Hussain1, Vwani Roychowdhury3, William Speier2, Hiroki Nariai1 (1.Division of Pediatric Neurology, Department of Pediatrics, UCLA Mattel Children’s Hospital, David Geffen School of edicine, Los Angeles, CA, USA, 2.Department of Radiological Sciences and Bioengineering, University of California, Los Angeles, CA, USA, 3.Department of Electrical and Computer Engineering, University of California, Los Angeles, CA, USA, 4.Department of Radiology, UCLA Medical Center, David Geffen School of Medicine, Los Angeles, CA, USA, 5.Department of Neurosurgery, UCLA Medical Center, David Geffen School of Medicine, Los Angeles, CA, USA)
[BIO-03]Functional verification and allele-specific silencing of an AKT3 variant that causes megalencephaly and epilepsy
○Yosuke Miyamoto1, Eisuke Ichise1, Takenori Tozawa1, Tatsuji Hasegawa1, Masafumi Morimoto2, Takahiro Fujimoto3, Kyoko Itoh3, Tomohiro Chiyonobu1,4 (1.Department of Pediatrics, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto, Japan, 2.Department of Medical Science,Department of Medical Science, School of Nursing, Kyoto Prefectural University of Medicine, Kyoto, Japan, 3.Department of Pathology and Applied Neurobiology Kyoto Prefectural University of Medicine, Kyoto, Japan, 4.Department of Molecular Diagnostics and Therapeutics, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto, Japan)
[BIO-04]D-Serine treatment ameliorates NMDA receptor dysfunction and behavioral deficits in Setd1a haploinsufficient mice
○Shuhei Fujino1,2, Kazuto Sakoori1,3, Kenichiro Nagahama1,4, Takaki Watanabe1,5, Akira Oka2,6, Motohiro Kato2, Masanobu Kano1,5 (1.Department of Neurophysiology, University of Tokyo, Tokyo, Japan, 2.Department of Pediatrics, University of Tokyo, Tokyo, Japan, 3.Laboratory of Molecular Physiology and Pharmacology, Teikyo University, Tokyo, Japan, 4.Department of Neuroscience, Johns Hopkins University, Baltimore, MD, USA, 5.Division of Complex System and Cognitive Sciences, Advanced Comprehensive Research Organization, Teikyo University, Tokyo, Japan, 6.Saitama Prefectural Children’s Medical Center, Saitama, Japan)
[BIO-05]Potential for MELAS treatment with highly-purified MSCs (RECs) by transferring and degrading mitochondria
○Jiahao Yang1, Liu Lu1, Yoshinori Otani2, Naoyo kajitani3, Miho Hattori3, Yasuaki Oda1, Masashi Fujitani2, Takeshi Taketani1 (1.Department of pediatrics, Shimane Universiy Faculty of Medicine, Shimane, Japan, 2.Department of Anatomy and Neuroscience, Shimane Universiy Faculty of Medicine, Shimane, Japan, 3.Regenerative Medical Center, Shimane University Hospital, Shimane, Japan)
[BIO-06]Genotype-phenotype relationships in NEB-related myopathies
○Masashi Ogasawara1,2, Yukako Yae 2, Ichizo Nishino2 (1.Department of Pediatrics, Showa General Hospital, Tokyo, Japan, 2.Department of Neuromuscular Research, National Institute of Neuroscience, National Center of Neurology and Psychiatry (NCNP))